Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001140361-25-004495·Kluge Andreas
Schedule 13G ownership disclosure
TELIX PHARMACEUTICALS LTD
Ordinary Shares · CUSIP: 87961M105
Event date: 2024-11-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Kluge Andreas
Shares: 22,675,000 · Class: 6.78%
- Gnosis Verwaltungsgesellschaft m.b.H.
Shares: 22,675,000 · Class: 6.78%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-25-004495
- Form type
- SCHEDULE 13G
- Filer
- Kluge Andreas
- CIK
- CIK 2037921
- Filed
- Feb 14, 2025
- Reporting period
- Nov 12, 2024
- Description
- Schedule 13G beneficial ownership